Sunday, July 28, 2019 9:27:47 PM
Why is Linda Powers in the picture with 5 year gbm dc vax L survivor, Mr. Power ? see Kristen Power Tweet at $nwbo
Kristyn Power
@KristynPower
·
9h
Today we celebrate my Dad passing the 5-year milestone with GBM. We are thankful for the ongoing support from the CCI Edmonton and Northwest Biotherapeutics, and especially for the hours of caregiving my Mom offers every single day! Go Dad! #GBM #Glioblastoma $NWBO
Image
MarketTruth
@tbinfo1
·
Jul 27
Replying to
@NSkiF1j1
@DLaBeck
and
@MeghanMcCain
Hey Dr Trelos (crazy) thought you were bashing $nwbo, now you are saying DCVax-L has promising data?
John Lane
@johnlane45
·
Jul 26
Kristyn Power
@KristynPower
·
9h
Today we celebrate my Dad passing the 5-year milestone with GBM. We are thankful for the ongoing support from the CCI Edmonton and Northwest Biotherapeutics, and especially for the hours of caregiving my Mom offers every single day! Go Dad! #GBM #Glioblastoma $NWBO
Image
MarketTruth
@tbinfo1
·
Jul 27
Replying to
@NSkiF1j1
@DLaBeck
and
@MeghanMcCain
Hey Dr Trelos (crazy) thought you were bashing $nwbo, now you are saying DCVax-L has promising data?
John Lane
@johnlane45
·
Jul 26
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
